Quest Diagnostics PE Ratio 2010-2024 | DGX

Current and historical p/e ratio for Quest Diagnostics (DGX) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Quest Diagnostics PE ratio as of July 24, 2024 is 16.09.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Quest Diagnostics PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-07-24 143.91 26.75
2024-06-30 136.15 $5.38 25.31
2024-03-31 131.64 $7.43 17.72
2023-12-31 135.64 $7.49 18.11
2023-09-30 119.19 $6.66 17.90
2023-06-30 136.79 $6.87 19.91
2023-03-31 137.00 $6.78 20.21
2022-12-31 150.81 $7.92 19.04
2022-09-30 117.66 $10.17 11.57
2022-06-30 126.90 $12.02 10.56
2022-03-31 129.96 $15.02 8.65
2021-12-31 163.55 $15.56 10.51
2021-09-30 136.77 $16.65 8.21
2021-06-30 123.64 $16.77 7.37
2021-03-31 119.66 $13.17 9.09
2020-12-31 110.62 $10.44 10.60
2020-09-30 105.76 $8.09 13.07
2020-06-30 104.77 $5.51 19.01
2020-03-31 73.30 $5.81 12.62
2019-12-31 97.00 $6.28 15.45
2019-09-30 96.73 $5.34 18.11
2019-06-30 91.54 $5.31 17.24
2019-03-31 80.38 $5.22 15.40
2018-12-31 73.96 $5.29 13.98
2018-09-30 95.39 $6.19 15.41
2018-06-30 96.75 $5.81 16.65
2018-03-31 87.82 $5.61 15.65
2017-12-31 85.85 $5.50 15.61
2017-09-30 81.23 $4.77 17.03
2017-06-30 96.03 $4.96 19.36
2017-03-31 84.44 $4.96 17.02
2016-12-31 78.64 $4.50 17.48
2016-09-30 72.42 $4.70 15.41
2016-06-30 69.00 $5.71 12.08
2016-03-31 60.22 $5.15 11.69
2015-12-31 59.63 $4.87 12.24
2015-09-30 51.21 $4.87 10.52
2015-06-30 60.10 $3.40 17.68
2015-03-31 63.37 $3.51 18.05
2014-12-31 55.03 $3.80 14.48
2014-09-30 49.52 $3.48 14.23
2014-06-30 47.64 $5.28 9.02
2014-03-31 46.75 $5.43 8.61
2013-12-31 42.97 $5.57 7.71
2013-09-30 49.59 $4.94 10.04
2013-06-30 48.43 $3.27 14.81
2013-03-31 44.88 $3.31 13.56
2012-12-31 45.83 $3.45 13.29
2012-09-30 49.89 $4.30 11.60
2012-06-30 46.99 $4.36 10.78
2012-03-31 47.84 $4.27 11.20
2011-12-31 45.16 $4.14 10.91
2011-09-30 38.31 $3.91 9.80
2011-06-30 45.87 $3.97 11.55
2011-03-31 44.65 $4.02 11.11
2010-12-31 41.67 $4.05 10.29
2010-09-30 38.97 $4.06 9.60
2010-06-30 38.27 $3.95 9.69
2010-03-31 44.75 $3.89 11.50
2009-12-31 46.28 $3.88 11.93
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $15.659B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.078B 11.54
DaVita (DVA) United States $12.441B 15.45
Encompass Health (EHC) United States $8.734B 22.36
Chemed (CHE) United States $8.195B 25.40
Elanco Animal Health (ELAN) United States $6.553B 17.00
Option Care Health (OPCH) United States $5.453B 20.64
RadNet (RDNT) United States $4.806B 100.08
Amedisys (AMED) United States $3.194B 22.63
Astrana Health (ASTH) United States $2.869B 38.81
Addus HomeCare (ADUS) United States $2.193B 28.38
LifeStance Health (LFST) United States $2.129B 0.00
U.S Physical Therapy (USPH) United States $1.460B 39.08
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Pennant (PNTG) United States $0.873B 46.13
Atai Life Sciences (ATAI) Germany $0.263B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.027B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.013B 0.00
Ontrak (OTRK) United States $0.013B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00